Exelixis (EXEL) Interest Coverage Ratio Growth (3y) (2013 - 2018)
Powered by 
Analysis
Exelixis (EXEL) Interest Coverage Ratio Growth (3y) (2013 - 2018) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 29.79% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -44.22% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 33.30% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -35.50% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 81.16% |
| 10 | Exelixis | 14.81 Bn | 13.97 Bn | 608.03 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 28, 2018 | 3,174.66% |
| Jun 30, 2017 | 48.08% |
| Mar 31, 2017 | 41.39% |
| Dec 30, 2016 | 39.87% |
| Sep 30, 2016 | 29.85% |
| Jun 30, 2016 | 19.23% |
| Mar 31, 2016 | -15.79% |
| Sep 30, 2015 | -2.47% |
| Jun 30, 2015 | 31.10% |
| Mar 31, 2015 | 30.93% |
| Dec 31, 2014 | -39.01% |
| Sep 30, 2014 | -30.42% |
| Jun 30, 2014 | -5.69% |
| Mar 31, 2014 | 2.81% |
| Dec 31, 2013 | -48.99% |
| Sep 30, 2013 | -68.25% |
| Jun 30, 2013 | 50.70% |